The impact of COVID-19 on harm reduction in seven Asian countries  Understanding the impact of COVID-19 on harm reduction funding and service provision is essential for informing donor and government action as well as civil society advocacy. T…

Webinar. What can we learn from the COVID-19 pandemic? COVID-19 and the impact on harm reduction in Europe Since the beginning of 2020, European countries have experienced an unprecedented public health threat with the emergence of COVID-19. In res…

Brasilien. Community-led advocacy (un)interrupted in Brazil In Brazil, the efforts of the É de Lei Community Centre to promote humane drug policy and harm reduction have been seriously disrupted by the COVID-19 pandemic. Amidst s…

Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.  Wilkinson, R., Hines, L., Holland, A. et al.  Harm Reduct J 17, 95 (…

INPUD. Peers in the Pandemic (9 November - 11 December, 2020) COVID-19 has exposed the failure of our health systems to adequately provide the services and care people need. As is too often the case in times of crisis, people who use drugs hav…

Irland. Needle exchange provision during Covid-19 pandemic  The current national drugs strategy aims to reduce harms arising from substance misuse and to reduce the prevalence of blood-borne viruses among people who inject drugs (PWID) through…